InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by SANTE HOLDINGS SRL limited liability company, Shareholder. Insider active across 2 companies, notably CARMAT. In total, 9 filings have been published. Total volume traded: €936k. The latest transaction was filed on 4 February 2025 (Souscription). Regulator: AMF. The full history is free.
Declarations9 total
€3m4,545,454 shares@ €0.77100.0% of flow
ActionEuronext Growth Paris
2025DD1019269·
€3m1,906,250 shares@ €1.60100.0% of flow
ActionEuronext Growth Paris
2024DD999234·
€4m1,343,333 shares@ €3.0072.9% of flow
ActionEuronext Growth Paris
2024DD967992·
€91,5587,000 shares@ €13.07970.0010% mcap7.4% of flow
ActionEuronext Paris
2024DD953626·
Ideal exit: 26 Nov 2024 (T+270)
€1m375,939 shares@ €3.9927.1% of flow
ActionEuronext Growth Paris
2024DD948708·
S
SANTE HOLDINGS SRL società a responsabilità limitata (limited liability company incorporated in Italy)board member permanently€7m1,944,442 shares@ €3.60100.0% of flow
ActionEuronext Growth Paris
2023DD934508·
€249,99738,461 shares@ €6.5020.2% of flow
Actionnewly issued shares subscribed in a capital increase
2023DD887087·
€844,360101,000 shares@ €8.360.0089% mcap68.1% of flow
ActionEuronext Paris
2022DD860615·
Ideal exit: 4 Jun 2023 (T+270)
€53,5301 shares@ €53,530.004.3% of flow
Titre de créanceHors plateforme de négociation
2022DD860616·
9 of 9 declarations
About SANTE HOLDINGS SRL limited liability company
SANTE HOLDINGS SRL is the investment vehicle associated with Dr. Antonino Ligresti, a well-known healthcare executive and long-standing reference shareholder of CARMAT. Within CARMAT, Santé Holdings SRL has played a supportive role in the company’s financing and shareholder stability, particularly through the multiple equity transactions used to fund the group’s industrial and clinical development. CARMAT’s financial communications repeatedly note Santé Holdings SRL’s participation in recent capital increases, underlining a durable commitment to the company’s long-term path. Dr. Antonino Ligresti, acting for Santé Holdings SRL, is a physician and surgeon by training, specialized in cardiology and internal medicine. He began his career at the Medical Clinic of the University of Milan and later at Fatebenefratelli Hospital in Milan. He went on to build extensive entrepreneurial and governance experience in healthcare, including a leading role in the creation of Italy’s first major private hospital group, and later board-level responsibilities in both listed and private healthcare companies. Sector sources and CARMAT materials also point to a profile shaped by board service, healthcare market access expertise, and commercial development insight. In the CARMAT context, Santé Holdings SRL belongs to the strategic shareholder base supporting the company’s mission to design and commercialize a fully implantable total artificial heart. The various financing rounds show that the investment vehicle helped sustain CARMAT’s financial continuity, notably during the 2023, 2024 and 2025 fundraises. This involvement reflects a governance profile well suited to a listed medtech company in an industrialization phase, where financial discipline, long-term vision and support through regulatory milestones are essential. Beyond its investor role, Santé Holdings SRL illustrates a governance approach grounded in medical-sector knowledge, active participation in capital decisions, and support for a high-impact healthcare innovation company. In CARMAT’s case, this shareholder anchor has helped secure several financing operations and strengthen the company’s market credibility.
